Medicare Enrolled

Dr. Heather Benjamin, M.D.

Medical Oncology · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
55 FRUIT ST, Boston, MA 02114
9788826060
In practice since 2006 (19 years)
NPI: 1619046604 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Benjamin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benjamin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Benjamin

Dr. Heather Benjamin is a medical oncology specialist in Boston, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Benjamin performed 399 Medicare services across 213 unique beneficiaries.

Between the years covered by Open Payments, Dr. Benjamin received a total of $142,657 from 38 pharmaceutical and/or device companies across 247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Benjamin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 23% volume in MA $142,657 industry payments

Medicare Practice Summary

Medicare Utilization ↗
399
Medicare services
Top 23% in MA for medical oncology
213
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $79 $326
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
120 $119 $481
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
104 $103 $335
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
30 $78 $311
New patient office visit, complex (60-74 min) 20 $157 $606
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$142,657
Total received (2018-2024)
Avg $20,380/year across 7 years
Top 12% in MA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
247
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69,516 (48.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$62,905 (44.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,237 (7.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$144
2023
$3,046
2022
$4,445
2021
$12,419
2020
$27,412
2019
$59,658
2018
$35,532

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$112
ABBVIE INC.
$32
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$44,303
AstraZeneca Pharmaceuticals LP
$37,224
Exelixis Inc.
$14,324
AbbVie, Inc.
$6,528
Eli Lilly and Company
$5,689
E.R. Squibb & Sons, L.L.C.
$5,021
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,982
Ipsen Biopharmaceuticals, Inc
$4,313
R-Pharm US LLC
$4,295
AMAG Pharmaceuticals, Inc.
$3,778
Mylan Institutional Inc.
$3,759
Hologic Sales and Service, LLC
$1,546
Pharmacosmos Therapeutics Inc.
$1,500
Takeda Pharmaceuticals U.S.A., Inc.
$1,193
EMD Serono, Inc.
$640
Becton, Dickinson and Company
$600
Daiichi Sankyo Inc.
$561
GlaxoSmithKline, LLC.
$425
GENZYME CORPORATION
$395
SANOFI-AVENTIS U.S. LLC
$300
Novocure GmbH
$200
Athenex Pharmaceutical Division, LLC
$175
Merck Sharp & Dohme Corporation
$163
Genentech USA, Inc.
$128
Helsinn Therapeutics (U.S.), Inc.
$117
United Therapeutics Corporation
$100
Janssen Biotech, Inc.
$65
Bayer HealthCare Pharmaceuticals Inc.
$64
Gilead Sciences, Inc.
$51
PFIZER INC.
$45
Novartis Pharmaceuticals Corporation
$43
ABBVIE INC.
$32
Pharmacyclics LLC, An AbbVie Company
$27
Astellas Pharma US Inc
$18
Eisai Inc.
$18
Cumberland Pharmaceuticals, Inc.
$12
Amgen Inc.
$11
Kyowa Kirin, Inc.
$11
Top 3 companies account for 67.2% of all-time payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · ALOXI · APTIMA · Avastin · BTX · Bavencio · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · ELITEK · Erleada · Ethyol · FARESTON · FERAHEME · GAZYVA · GILOTRIF · Halaven · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · Ixempra · JADENU · KEYTRUDA · LIBTAYO · MEKINIST · MONOFERRIC · NINLARO · Neulasta · OPDIVO · Ogivri · Onivyde · Perjeta · Rituxan Hycela · SPRYCEL · TAGRISSO · TECENTRIQ · UNITUXIN · VENCLEXTA · XTANDI · Xofigo · ZEJULA · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a medical oncology specialist in Boston?
Compare medical oncologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
233
Per 100K population
29.8
County median income
$92,859
Nearest hospital
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Benjamin is a clinical cardiology specialist, with above-average Medicare volume (top 23% in MA), with speaking/promotional industry engagement in the top 12% of MA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Benjamin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Benjamin performed 125 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benjamin receive payments from pharmaceutical companies?
Yes. Dr. Benjamin received a total of $142,657 from 38 companies across 247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benjamin's costs compare to other medical oncologists in Boston?
Dr. Benjamin's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benjamin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →